DOI: 10.12890/2024_004837

Life-threatening methaemoglobinaemia secondary to cetrimide

Authors

  • Radwan Zeidan Faculty of Medicine, University of Balamand, Beirut, Lebanon
  • Mohammed Abdallah Internal Medicine, University of Balamand, Beirut, Lebanon
  • Nazem Matta Department of Surgery, Mount Lebanon Hospital Balamand University Medical Center, Beirut, Lebanon
  • Patricia Nehme Department of Anesthesiology, University of Balamand, Beirut, Lebanon
  • Mirna Fares Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mount Lebanon Hospital Balamand University Medical Center, Beirut, Lebanon

radwan.zeidan.1@gmail.com

Keywords

Cetrimide, hypoxia, oxygen therapy, confusion, methaemoglobulinaemia

Abstract

Methaemoglobinaemia is a rare but potentially life-threatening condition in which there is diminution of the oxygen-carrying capacity of the circulating haemoglobin. It can result from either congenital or acquired processes. Acquired methaemoglobinaemia is more prevalent than congenital methaemoglobinaemia, and notably it has a higher prevalence in infants and neonates than in adults; it results from exposure to oxidising agents. Methaemoglobin forms when haemoglobin is oxidised to contain iron in the ferric (Fe3+) state rather than the normal ferrous (Fe2+) state. Methaemoglobinaemia is a clinical diagnosis and is suspected in the presence of hypoxaemia refractory to supplemental oxygen and in the presence of chocolate-coloured blood. Symptoms are usually dependent on the methaemoglobin levels; at levels higher than 35%, systemic symptoms from tissue hypoxia may be fatal. We present a case of severe life-threatening methaemoglobinaemia following intra-abdominal use of cetrimide during hydatid cyst removal in a 60-year-old female.

View the entire article

Downloads

References

  1. Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore) 2004;83:265–273.
  2. Tintinalli JE, Stapczynski JS, Ma OJ, Yealy DM, Meckle GD, Cline DM. Tintinalli’s emergency medicine: a comprehensive study guide. 8th ed. New York: McGraw-Hill Education; 2015.
  3. Baraka A, Yamut F, Wakid N. Cetrimide-induced methaemoglobinaemia after surgical excision of hydatid cyst. Lancet 1980;2:88–89.
  4. Frayha GJ, Bikhazi KJ, Kachachi TA. Treatment of hydatid cysts (Echinococcus granulosus) by Cetrimide®. Trans R Soc Trop Med Hyg 1981;75:447–450.
  5. Svecová D, Böhmer D. Vrodená a získaná methemoglobinémia a ich liecba [Congenital and acquired methemoglobinemia and its therapy]. Cas Lek Cesk 1998;137:168–170.
  6. Palamar JJ, Griffin-Tomas M, Ompad DC. Illicit drug use among rave attendees in a nationally representative sample of US high school seniors. Drug Alcohol Depend 2015;152:24–31.
  7. Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J 2011;104:757–761.
  8. Cefalu JN, Joshi TV, Spalitta MJ, Kadi CJ, Diaz JH, Eskander JP, et al. Methemoglobinemia in the operating room and intensive care unit: early recognition, pathophysiology, and management. Adv Ther 2020;37:1714–1723.

Published

2024-09-26

How to Cite

1.
Zeidan R, Abdallah M, Matta N, Nehme P, Fares M. Life-threatening methaemoglobinaemia secondary to cetrimide. EJCRIM [Internet]. 2024 Sept. 26 [cited 2026 Nov. 18];11(11). Available from: https://ojs.wedare.app/ejcrim/article/view/4837

Most read articles by the same author(s)